Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Folinic Acid in Pediatric Autism Spectrum Disorder
NCT07642661Phase 2Recruiting
- Start
- Jun 2026
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
A Phase 2 trial of folinic acid in Autism Spectrum Disorder (ASD). Started Jun 2026; status: recruiting.
02
Drugs
folinic acid
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT07642661.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07642661.